EUVIMEDDécouvrir EUVIMED
Crossref

Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch‐repair deficiency

Kenta Makino iD, Takamichi Ishii iD, Haruhiko Takeda iD, Yoichi Saito iD, Yukio Fujiwara iD, Masakazu Fujimoto, Takashi Ito, Satoshi Wakama, Ken Kumagai iD, Fumiaki Munekage, Hiroshi Horie, Katsuhiro Tomofuji and 8 more

The Journal of Pathology · 2024-05 · 263 (1) · 32-46

DOI: 10.1002/path.6257 ↗

At a glance

Journal article in The Journal of Pathology, published online on 2024-02-16. Written by Kenta Makino and 19 co-authors. Institution: Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Major MEDLINE topics: Liver Neoplasms, Carcinoma, Hepatocellular, Cholangiocarcinoma, Bile Duct Neoplasms. Cited 10 times so far (Crossref); 70 references. Funded by: Japan Society for the Promotion of Science.

RésuméSubjectsRéférences bibliographiquesCiteRelated studies

Abstract (original language)

Cholangiolocarcinoma (CLC) is a primary liver carcinoma that resembles the canals of Hering and that has been reported to be associated with stem cell features. Due to its rarity, the nature of CLC remains unclear, and its pathological classification remains controversial. To clarify the positioning of CLC in primary liver cancers and identify characteristics that could distinguish CLC from other liver cancers, we performed integrated analyses using whole‐exome sequencing (WES), immunohistochemistry, and a retrospective review of clinical information on eight CLC cases and two cases of recurrent CLC. WES demonstrated that CLC includes IDH1 and BAP1 mutations, which are characteristic of intrahepatic cholangiocarcinoma (iCCA). A mutational signature analysis showed a pattern similar to that of iCCA, which was different from that of hepatocellular carcinoma (HCC). CLC cells, including CK7, CK19, and EpCAM, were positive for cholangiocytic differentiation markers. However, the hepatocytic differentiation marker AFP and stem cell marker SALL4 were completely negative. The immunostaining patterns of CLC with CD56 and epithelial membrane antigen were similar to those of the noncancerous bile ductules. In contrast, mutational signature cluster analyses revealed that CLC formed a cluster associated with mismatch‐repair deficiency (dMMR), which was separate from iCCA. Therefore, to evaluate MMR status, we performed immunostaining of four MMR proteins (PMS2, MSH6, MLH1, and MSH2) and detected dMMR in almost all CLCs. In conclusion, CLC had highly similar characteristics to iCCA but not to HCC. CLC can be categorized as a subtype of iCCA. In contrast, CLC has characteristics of dMMR tumors that are not found in iCCA, suggesting that it should be treated distinctly from iCCA. © 2024 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularCholangiocarcinomaBile Duct NeoplasmsBrain NeoplasmsNeoplastic Syndromes, HereditaryColorectal NeoplasmsHumansBile Ducts, Intrahepatic

Author keywords

cholangiolocarcinomacholangiolocellular carcinomagene mutationgenetic landscapeintrahepatic cholangiocarcinomaliver cancermismatch‐repair deficiencywhole‐exome sequencing

Authors and institutions

  • Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Laboratory of Bioengineering, Faculty of Advanced Science and Technology, Kumamoto University, Kumamoto, Japan.
  • Department of Cell Pathology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Diagnostic Pathology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Surgery, Medical Research Institute Kitano Hospital, Osaka, Japan.

ORCID profiles: Kenta Makino, Takamichi Ishii, Haruhiko Takeda, Yoichi Saito, Yukio Fujiwara, Ken Kumagai, Etsuro Hatano

Funding

  • Japan Society for the Promotion of Science

Cite

APA

Makino, K., Ishii, T., Takeda, H., Saito, Y., Fujiwara, Y., Fujimoto, M., Ito, T., Wakama, S., Kumagai, K., Munekage, F., Horie, H., Tomofuji, K., Oshima, Y., Uebayashi, E. Y., Kawai, T., Ogiso, S., Fukumitsu, K., Takai, A., Seno, H., & Hatano, E. (2024). Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch‐repair deficiency. The Journal of Pathology, 263(1), 32-46. https://doi.org/10.1002/path.6257

Vancouver

Makino K, Ishii T, Takeda H, Saito Y, Fujiwara Y, Fujimoto M, et al. Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch‐repair deficiency. The Journal of Pathology. 2024;263(1):32-46. doi:10.1002/path.6257

BibTeX
@article{Makino2024,
  author = {Makino, Kenta and Ishii, Takamichi and Takeda, Haruhiko and Saito, Yoichi and Fujiwara, Yukio and Fujimoto, Masakazu and Ito, Takashi and Wakama, Satoshi and Kumagai, Ken and Munekage, Fumiaki and Horie, Hiroshi and Tomofuji, Katsuhiro and Oshima, Yu and Uebayashi, Elena Yukie and Kawai, Takayuki and Ogiso, Satoshi and Fukumitsu, Ken and Takai, Atsushi and Seno, Hiroshi and Hatano, Etsuro},
  title = {Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch‐repair deficiency},
  journal = {The Journal of Pathology},
  year = {2024},
  volume = {263},
  number = {1},
  pages = {32--46},
  doi = {10.1002/path.6257}
}
Start for free →